Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Outcomes and prognosis news

Show

From To
ART in Africa bridges health gap between those with, without HIV

The expansion of ART for HIV infection has helped reduce disparities in health-related quality of life between HIV-positive and HIV-negative individuals in Zambia and South Africa, according to findings published in The Lancet Global Health.

Published
13 October 2017
From
Healio
Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection,

Published
03 October 2017
By
Michael Carter
South Africa death rates declined due to HIV success – report

Death rates have declined, largely due to successes in HIV, but a lot more needs to be done to defeat its “terrible twin”, tuberculosis (TB).

Published
23 August 2017
From
Health-e
Viral Rebound Unlikely for Many on ART

British investigators have determined that a substantial proportion of people with HIV who are taking antiretroviral therapy (ART) will not experience viral rebound during their lifetime.

Published
14 July 2017
From
Infectious Disease Special Edition
Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the

Published
05 July 2017
By
Michael Carter
Life insurance policyholders with HIV urged to review life cover term

People with HIV who took out life insurance between 2009 and 2013 should review their policy, Unusual Risks has urged.

Published
24 May 2017
From
Professional Adviser
The HIV story is not over - the spectre of anti-science threatens our advances

The life expectancy of people with HIV is now ‘near normal’, but complacency would be wrong.

Published
17 May 2017
From
The Guardian
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
HIV life expectancy 'near normal' thanks to new drugs

Newer medications have fewer side effects and are more efficient at stopping the virus.

Published
11 May 2017
From
BBC Health
New Study Reveals why people with HIV are more likely to develop Emphysema

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema in their lifetime. Now, new research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Published
10 May 2017
From
Weill Cornell Medicine
← First12345...35Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.